Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Stage-specific efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer according to baseline genetic alterations in circulating tumor DNA.
Taniguchi Y, Tamiya A, Osuga M, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Shimada M, Ando M, Koh Y. Taniguchi Y, et al. Among authors: shinohara t. Invest New Drugs. 2025 Jan 9. doi: 10.1007/s10637-024-01500-9. Online ahead of print. Invest New Drugs. 2025. PMID: 39789369
High Shear Stress Reduces ERG Causing Endothelial-Mesenchymal Transition and Pulmonary Arterial Hypertension.
Shinohara T, Moonen JR, Chun YH, Lee-Yow YC, Okamura K, Szafron JM, Kaplan J, Cao A, Wang L, Guntur D, Taylor S, Isobe S, Dong M, Yang W, Guo K, Franco BD, Pacharinsak C, Pisani LJ, Saitoh S, Mitani Y, Marsden AL, Engreitz JM, Körbelin J, Rabinovitch M. Shinohara T, et al. Arterioscler Thromb Vasc Biol. 2024 Dec 26. doi: 10.1161/ATVBAHA.124.321092. Online ahead of print. Arterioscler Thromb Vasc Biol. 2024. PMID: 39723537
Pathological Complete Response to a Single Dose of Pembrolizumab-Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report.
Matsumura Y, Ichihara S, Nii K, Nanjo K, Kadota N, Okano Y, Machida H, Hatakeyama N, Hino H, Naruse K, Shinohara T, Sakiyama S, Takeuchi E. Matsumura Y, et al. Among authors: shinohara t. Thorac Cancer. 2025 Jan;16(2):e15519. doi: 10.1111/1759-7714.15519. Epub 2024 Dec 17. Thorac Cancer. 2025. PMID: 39688181 Free PMC article.
Hypoxia-inducible factor-targeting therapy augmented the sensitivity to programmed death ligand-1 blockade by enhancing interferon-γ-induced chemokines in tumor cells.
Yabuki Y, Mitsuhashi A, Ogino H, Yoshida A, Nguyen NT, Yoneda H, Ozaki R, Tsukazaki Y, Morita Y, Nokihara H, Sato S, Shinohara T, Hanibuchi M, Nishioka Y. Yabuki Y, et al. Among authors: shinohara t. Int J Cancer. 2024 Dec 17. doi: 10.1002/ijc.35301. Online ahead of print. Int J Cancer. 2024. PMID: 39686841
1,337 results